ArticleOpen forum infectious diseases2019

Cost-Effectiveness of Preemptive Switching to Efavirenz-Based Antiretroviral Therapy for Children With Human Immunodeficiency Virus.

Sophie Desmonde et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.